ArticleFrontiers in public health2022

Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study.

Shuxia Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.